INNOVATE BIOPHARMACEUTICALS, INC - 48 Year Dividend Yield History | INNT

Historical dividend payout and yield for INNOVATE BIOPHARMACEUTICALS, INC (INNT) since 1971. The current TTM dividend payout for INNOVATE BIOPHARMACEUTICALS, INC (INNT) as of February 20, 2019 is $0.00. The current dividend yield for INNOVATE BIOPHARMACEUTICALS, INC as of February 20, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.056B $0.002B
Innovate Biopharmaceuticals, Inc. is a clinical stage biotechnology company. It focused on developing novel medicines for autoimmune/ inflammatory disease. The company's pipeline includes drug candidates for celiac disease, an unmet need, and ulcerative colitis. Its products includes INN-202 for the treatment of Celiac Disease with fast track designation, INN-108 for Inflammatory Bowel Disorders, mild to moderate Ulcerative Colitis and a GI orphan disease in a convenient liquid formulation, INN-329 for Magnetic Resonance Cholangiopancreatography which are in clinical stages. Innovate Biopharmaceuticals Inc., formerly known as Monster Digital, Inc., is based in SIMI VALLEY, United States.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $116.316B 12.97
Gilead Sciences (GILD) United States $86.647B 10.87
Bio-Techne Corp (TECH) United States $7.316B 49.29